Oncology Program at Presbyterian Dallas Receives Top Accreditation From Commission on Cancer|
DALLAS — Presbyterian Hospital of Dallas has received the highest accreditation for comprehensive cancer programs from the American College of Surgeons Commission on Cancer.
Presbyterian Hospital of Dallas received commendations in all nine categories for a community hospital to be designated an approved cancer center by the commission. The hospital is eligible for the commission's Outstanding Achievement award, which will be announced in the first quarter of 2009.
In 2005, Presbyterian Hospital of Dallas was first named an approved cancer program by the commission and received the Outstanding Achievement award that year — one of only two centers in Texas to receive the honor.
To qualify as an approved cancer center, a hospital must treat a high number of cancer patients each year, provide a full range of diagnostic and treatment services, and participate in clinical research. The hospital must also provide a cancer registry that follows patients from diagnosis through treatment and offers lifelong follow-up. Presbyterian exceeded the criteria in all categories.
"It is quite an honor to receive this recognition because only institutions that meet the high standards set by the American College of Surgeons Commission on Cancer receive the designation," said Mark H. Merrill, president of Presbyterian Hospital of Dallas. "In fact, only one in four hospitals that treat cancer patients has approved cancer programs, and we remain a part of this group."
Receiving accreditation involves meeting a complex set of requirements for a hospital's oncology services, said Dr. Pat Fulgham, surgical director of oncology. "Receiving this designation validates Presbyterian Hospital of Dallas' commitment to clinical excellence and compassionate, patient-centered care," he said.
The application process, which included a site visit, requires that hospitals submit three years of data to demonstrate that the program meets the commission's rigorous standards for providing comprehensive care for cancer patients, including state-of-the-art equipment and services, and maintaining a multidisciplinary approach to patient care.
The patient data collected by certified tumor registrars at Presbyterian Hospital of Dallas is provided to researchers and organizations such as the American Cancer Society, National Cancer Institute and Centers for Disease Control to evaluate quality of care, outcomes, and screening and prevention programs.
About Presbyterian Hospital of Dallas (PHD)
Established in 1966, PHD is the flagship hospital of Presbyterian Healthcare System, a member of the faith-based, nonprofit Texas Health Resources system. U.S. News and World Report ranks PHD, a recognized clinical program leader, providing technologically advanced care to patients, among the nation’s best hospitals in digestive disorders, orthopedics, and neurology and neurosurgery. The 866-bed facility has approximately 4,000 employees and an active medical staff of more than 1,000 physicians. For more information about PHD, visit www.texashealth.org/phd.
About Texas Health Resources
Texas Health Resources is one of the largest faith-based, nonprofit health care delivery systems in the United States and the largest in North Texas in terms of patients served. THR’s system of 13 hospitals includes Harris Methodist Hospitals, Arlington Memorial Hospital and Presbyterian Healthcare System, and a medical research organization. THR is a corporate member or partner in six additional hospitals and surgery centers. For more information about Texas Health Resources, visit www.texashealth.org.